People · Operator

John Hollister

Named in public records as an officer, director or promoter · active 2014–2016 · Business Services, Pharmaceuticals

2
Companies
2
Filings
$10.7M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Northsight Capital, Inc.Business ServicesSeries A$8.8M$4.7M2016
NemusPharmaceuticalsSeed$1.9M$17.3M2014
Operator network

John Hollister at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

John Gorman · 7 companies · 1 sharedJohn GormanJohn Venners · 3 companies · 1 sharedJohn VennersThomas Dean · 3 companies · 1 sharedThomas DeanHoward Baer · 2 companies · 1 sharedHoward BaerJohn B Hollister · 2 companies · 1 sharedJohn B HollisterHoward B Baer · 1 companies · 1 sharedHoward B BaerJohn Bluher · 1 companies · 1 sharedJohn BluherRandy R. Rhoden · 1 companies · 1 sharedRandy R. RhodenWilliam Lupo · 1 companies · 1 sharedWilliam LupoBrian Murphy · 15 companies · 1 sharedBrian MurphyDavid Skibinski · 3 companies · 1 sharedDavid SkibinskiCosmas Lykos · 1 companies · 1 sharedCosmas LykosElizabeth Berecz · 1 companies · 1 sharedElizabeth BereczJerry McLaughlin · 1 companies · 1 sharedJerry McLaughlinReg Lapham · 1 companies · 1 sharedReg LaphamNorthsight Capital, Inc. · $8.8M raisedNorthsight Capital, I…Nemus · $1.9M raisedNemusJohn HollisterJH
John Hollister Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside John Hollister on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Brian Murphy115
John Gorman17
John Venners13
Thomas Dean13
David Skibinski13
Howard Baer12
John B Hollister12
Reg Lapham11
Howard B Baer11
Jerry McLaughlin11
Elizabeth Berecz11
Cosmas Lykos11
Randy R. Rhoden11
John Bluher11
William Lupo11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.